MILD COGNITIVE IMPAIRMENT TEST NO FURTHER A MYSTERY

Since individuals that carry the APOE e4 gene variant surface to have a increased risk of great troubles, the FDA recommends staying tested for your gene variant before beginning treatment with lecanemab or donanemab.PET scans. These scans can present designs of brain activity. They can figure out whether or not amyloid or tau protein, hallmarks of